Evidence map›Paper›PMID 42363766›Full record

ArticleNucleic acids research2026

Antibody-trapping presents a widespread pitfall for microscopy and genomics in the nucleus.

Konrad Chudzik, Yuko Sato, Xingchi Yan, Simon Ullrich, Watanya Trakarnphornsombat, Lothar Schermelleh, Geoffrey Fudenberg, Hiroshi Kimura, Michael I Robson, Irina Solovei

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Konrad ChudzikMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Chromatin (dys)function in disease group, Berlin, 10115, Germany.ORCID 0000-0002-7606-8381
Yuko SatoCell Biology Center, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama, 226-8501, Japan.ORCID 0000-0002-7805-9171
Xingchi YanDepartment of Quantitative and Computational Biology, University of Southern California, Los Angeles, CA 90089, United States.ORCID 0000-0003-3525-0942
Simon UllrichFaculty of Biology, Ludwig Maximilians University Munich, Planegg-Martinsried, 82152, Germany.
Watanya TrakarnphornsombatSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama, 226-8501, Japan.
Lothar SchermellehDepartment of Biochemistry, University of Oxford, Oxford, OX1 3QU, United Kingdom.
Geoffrey FudenbergDepartment of Quantitative and Computational Biology, University of Southern California, Los Angeles, CA 90089, United States.ORCID 0000-0001-5905-6517
Hiroshi KimuraCell Biology Center, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama, 226-8501, Japan.ORCID 0000-0003-0854-083X
Michael I RobsonMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Chromatin (dys)function in disease group, Berlin, 10115, Germany.ORCID 0000-0003-1126-3538
Irina SoloveiFaculty of Biology, Ludwig Maximilians University Munich, Planegg-Martinsried, 82152, Germany.

Funding

Genomes in 3D: from maps to mechanismsR35GM143116 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI FUDENBERG, GEOFFREY · 2021 to 2025
$2.1M
BINDS JP25ama121020Deutsche Forschungsgemeinschaft IRTG2403DFG # 213249687DFG 2841DFG # 400728090DFG # 422388934DFG # 556274722DFG # 563470554DFG SFB1064DFG SP2202/SO1054/2DFG SPP 2502European Molecular Biology Organization ALTF1554-2016Human Frontier Science Program RGP020/2025Innovative Research Ecosystem 24jf026008h0001Japan Agency for Medical Research and DevelopmentJapan Science and Technology Agency JPMJCR20S6Japan Society for the Promotion of Science JP21H04764Japan Society for the Promotion of Science JP24H02325NIH HHS R35GM143116Wellcome Trust 206475/Z/17/Z
6 · The paper itself

Abstract

Chromatin has a complex 3D structure and diverse binding proteins that coordinate the genome's most essential functions. Many microscopy and genomics technologies that map chromatin proteins and modifications rely on the diffusion of antibodies (Abs) to target epitopes within whole nuclei. Here, we reveal a critical flaw in such methods that arises when Abs become trapped at the edge of nuclear structures and fail to reach internally positioned epitopes. This "Ab-trapping" results in artifactual peripheral signal that fundamentally distorts the apparent positions of chromatin features across the genome and nucleus. Using computational modeling and experimental validation, we demonstrate that Ab-trapping is caused by a combination of three compounding factors-high epitope abundance, high Ab affinity, and low Ab diffusion rates. Ab-trapping can thus systematically misrepresent the localization of many prevalent chromatin features like histone modifications, transcription factors, nucleolar proteins, and protein tags. We also show that this artifact manifests in multiple technologies, including immunofluorescence microscopy, more recent CUT&Tag-seq, and likely any method relying on Ab diffusion. Finally, we outline readily implementable strategies to identify and mitigate Ab-trapping. Combined, our work presents a previously unrecognized yet prevalent artifact in Ab-based chromatin mapping methods and the means to resolve it.

Indexed as

AntibodiesCell NucleusChromatinGenomicsAnimalsArtifactsEpitopesHumansMicroscopy, FluorescenceAntibodiesChromatinEpitopes

Identifiers

PMID42363766
PMCPMC13309790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.